|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/37 | |
| A61K 35/14 |
| (11) | Patento numeris | 2635297 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11838863.6 |
| Europos patento paraiškos padavimo data | 2011-11-04 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-09-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-02-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2011/059297 |
| Data | 2011-11-04 |
| (87) | Numeris | WO 2012/061689 |
| Data | 2012-05-10 |
| (30) | Numeris | Data | Šalis |
| 410437 P | 2010-11-05 | US |
| (72) |
LAI, Chee Kong, US
STAFFORD, Roddy, Kevin, US
|
| (73) |
Baxalta Incorporated,
1200 Lakeside Drive, Bannockburn, IL 60015,
US
Baxalta GmbH, Zählerweg 4, 6300 Zug, CH |
| (54) | A NEW VARIANT OF ANTIHEMOPHILIC FACTOR VIII HAVING INCREASED SPECIFIC ACTIVITY |
| A NEW VARIANT OF ANTIHEMOPHILIC FACTOR VIII HAVING INCREASED SPECIFIC ACTIVITY |